Search filters

List of works by Ariela Noy

A new prognostic score for AIDS-related lymphomas in the rituximab-era

scientific article

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.

scientific article published on 8 May 2015

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 15 February 2019

Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease*

scientific article published on 01 June 2004

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

scientific article published on 3 April 2003

Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team

article

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients

article

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

scientific article published on 28 January 2015

Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol

scientific article

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy

scientific article published on 01 September 2000

Controversies in the treatment of Burkitt lymphoma in AIDS

scientific article published on September 1, 2010

Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma.

scientific article

Developing a cancer-specific geriatric assessment

scientific article published on 01 November 2005

Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification.

scientific article published on 17 March 2011

Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma

scientific article

Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.

scientific article published in December 2009

Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Detected by Clonotypic Polymerase Chain Reaction Despite Continuous Pathologic Remission Induced by Involved-Field Radiotherapy

scientific article published on 01 June 2005

HIV multicentric Castleman: rituximab sans maintenance

scientific article published in April 2017

High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging

scientific article published on 18 January 2010

Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma

scientific article

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas

scientific article published on 19 August 2015

Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy

scientific article published on 26 October 2007

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

scientific article

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma

scientific article published in September 2003

Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent

scientific article published in May 2015

MCD & HHV-8 viral load

scientific article published on 01 July 2011

Neurological Complications of Non-Hodgkin Lymphoma

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.

scientific article published on 19 December 2011

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium

scientific article

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study

scientific article published on 13 February 2015

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047

scientific article

Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation

scientific article published on 25 September 2009

Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma

scientific article published on 23 February 2011

Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation

scientific article

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma

scientific article

Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.

scientific article published on 30 December 2013

Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome

scientific article published on 01 January 2007

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

scientific article published in November 2007

Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.

scientific article

R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy

scientific article published in April 2005

Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer

scientific article

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

scientific article

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma

scientific article published on 8 March 2010

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

scientific article

Rituximab for Aggressive Non-Hodgkin??s Lymphomas Relapsing After or Refractory to Autologous Stem Cell Transplantation

scientific article published on 01 September 2002

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

scientific article

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

article

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses

scientific article published on 15 December 2008

Spectrum of HIV lymphoma 2009.

scientific article published on July 2010

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience

scientific article

Successful management of gastric perforation in stage IV diffuse large B-cell lymphoma with chemoradiation therapy, percutaneous endoscopy gastrostomy for gastric drainage, and percutaneous endoscopy jejunostomy for nutrition

scientific article

Successful treatment of marginal zone lymphoma with splenectomy alone despite HIV infection

scientific article published in July 2007

Telomeres: the long and short of developing non-Hodgkin lymphoma

scientific article

The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL).

scientific article published on 12 January 2009

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

scientific article published on 06 September 2013

Update in Kaposi sarcoma

scientific article